NASDAQ:UTHR | Buybacks | UNITED THERAPEUTICS Corp

UTHR Buybacks

17 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–17; provenance stays internal.

Issuer profilePeriod endTypeReported cash
UNITED THERAPEUTICS Corp2026-03-31Reported repurchase cash$1.5B
UNITED THERAPEUTICS Corp2025-12-31Reported repurchase cash$0.00
UNITED THERAPEUTICS Corp2025-03-31Reported repurchase cash$0.00
UNITED THERAPEUTICS Corp2024-12-31Reported repurchase cash$0.00
UNITED THERAPEUTICS Corp2024-03-31Reported repurchase cash$1B
UNITED THERAPEUTICS Corp2023-12-31Reported repurchase cash$0.00
UNITED THERAPEUTICS Corp2023-03-31Reported repurchase cash$0.00
UNITED THERAPEUTICS Corp2017-12-31Reported repurchase cash$0.00
UNITED THERAPEUTICS Corp2016-12-31Reported repurchase cash$104.5M
UNITED THERAPEUTICS Corp2016-03-31Reported repurchase cash$123.2M
UNITED THERAPEUTICS Corp2015-12-31Reported repurchase cash$0.00
UNITED THERAPEUTICS Corp2015-03-31Reported repurchase cash$152.3M
UNITED THERAPEUTICS Corp2014-12-31Reported repurchase cash$79.94M
UNITED THERAPEUTICS Corp2014-03-31Reported repurchase cash$97.63M
UNITED THERAPEUTICS Corp2013-12-31Reported repurchase cash$1,000.00
UNITED THERAPEUTICS Corp2013-03-31Reported repurchase cash$5.9M
UNITED THERAPEUTICS Corp2012-12-31Reported repurchase cash$57.08M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.